Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

BACKGROUND: Oestrogens usually stimulate the progression of oestrogen receptor (ER)-positive breast cancer. Paradoxically, high-dose oestrogens suppress the growth of these tumours in certain circumstances. METHODS: We prospectively examined the efficacy and safety of ethinylestradiol treatment (3 m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Iwase, H, Yamamoto, Y, Yamamoto-Ibusuki, M, Murakami, K-I, Okumura, Y, Tomita, S, Inao, T, Honda, Y, Omoto, Y, Iyama, K-I
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2013
Subjects:	Clinical Study
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3777011/ https://ncbi.nlm.nih.gov/pubmed/24002591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.520
Tags:	Add Tag No Tags, Be the first to tag this record!

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

Similar Items